Developing Country NGO Delegation 43 Global Fund Board Meeting Constituency Statement

Find the statement made by the Developing Country NGO Delegation at the virtual 43 Global Fund Board meeting (14 – 15 May) as they urged the Global Fund not to forget their core business and principles in the development of the new strategy and the COVID-19 response, ensuring that civil society and communities are meaningfully involved. This important statement is available in different languages French Spanish Russian English

The Delegation affirmed Women4GlobalFund (W4GF) in our call for more action to address gender inequity in new Global Fund proposals including:

• calling on the Global Fund Secretariat to be explicit about the financial support (for community engagement and time on the CCM) that is allocated to civil society through the CCM budget, including (in some countries) for communities’ engagement during the country dialogue.
• calling on the Technical Review Panel (TRP) to return funding requests with specific and concrete guidance and instructions to revise and strengthen gender-sensitive and transformative interventions, programmes and services if they do not include interventions to address the needs and rights of key populations and women and girls.

They also called for more understanding on Strategic Objective 3 “While we appreciate the work of the Community, Rights and Gender Department for this report, we reiterate our statement from the 12th Committees and again request a Deep Dive on Strategic Objective 3 for the upcoming Strategy Committee and Board Meeting, to allow us to interrogate and understand what we can do to make Strategic Objective 3: Promoting and Protecting Human Rights and Gender Equality (SO3) a reality across: the Board; the Secretariat; Technical Partners; Implementers; and the populations we serve.  We recognise that the 2017 – 2019 cycle saw some increased inclusion of sex and age disaggregated data in funding proposals and performance frameworks, what will be done to increase the range of disaggregated data still needed, particularly for TB and malaria?”